A Study to Evaluate the Safety, Tolerability and Pharmacodynamics of DDP733 for IBS-c
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This study will evaluate the safety, tolerability and pharmacodynamics of the investigational
drug DDP733 in treating subjects with IBS-c. A placebo control will be utilized.